COVID-19 PORTFOLIO
BARDA has a proven track record of responding to pandemics and developing lifesaving medical countermeasures.
We have rapidly executed new partnerships and built a robust COVID-19 portfolio because Americans deserve to have safe, effective medical products.
This page is updated regularly, but may not include all awards
- All
- Vaccines
- Diagnostics
- Therapeutics
- Rapidly Deployable Capabilities
- Support Services
- Other
BARDA’s Impact on the COVID-19 Pandemic Response
Check out BARDA’s COVID-19 response dashboard, detailed response timeline, and more.
